Skip to main content
Top
Published in: Calcified Tissue International 5/2017

01-11-2017 | Case Reports

Skeletal Fluorosis Due to Fluorocarbon Inhalation from an Air Dust Cleaner

Authors: Katherine Peicher, Naim M. Maalouf

Published in: Calcified Tissue International | Issue 5/2017

Login to get access

Abstract

Skeletal fluorosis (SF) is an osteosclerotic metabolic bone disorder caused by excessive ingestion or inhalation of fluoride. SF is extremely rare in developed countries. We report a case of SF due to inhalational abuse from a fluoride-containing air dust cleaner. A 33-year-old man with no past medical history presented with progressively worsening low back pain for 2 years. Physical examination was notable for loss of lumbar lordosis and tenderness over the lumbar spine. Radiographs were notable for uniform generalized osteosclerosis in the long bones, entire spine, rib cage, and pelvic bones, and loss of the normal lumbar curvature. DXA scan showed Z-scores of +10.7 at the lumbar spine, +6.5 at the total hip, and +1.0 at the 1/3 radius. Laboratory studies were notable for elevated serum alkaline phosphatase (334 U/L, ref: 40–129 U/L) compared to a normal value 3 years prior, suggesting acquired osteosclerosis. Serum fluoride concentration returned elevated (2.8 mg/L, ref: 0.0–0.2 mg/L). Initially, the source of fluoride excess could not be identified. At a follow-up visit, he was found inhaling from a can of an air duster hidden in an inner pocket. He admitted “huffing” 2–7 cans weekly from a fluorocarbon-containing air dust cleaner for the past 3 years to achieve a euphoric feeling, explaining the source of his SF. Fluoride inhalation can be a potential source for SF, and should be suspected in patients with acquired osteosclerosis, as inhalant abuse is increasingly practiced in many countries.
Literature
1.
go back to reference Li Y, Liang C, Slemenda CW, Ji R, Sun S, Cao J, Emsley CL, Ma F, Wu Y, Ying P, Zhang Y, Gao S, Zhang W, Katz BP, Niu S, Cao S, Johnston CC (2001) Effect of long-term exposure to fluoride in drinking water on risks of bone fractures. J Bone Miner Res 16(5):932–939CrossRefPubMed Li Y, Liang C, Slemenda CW, Ji R, Sun S, Cao J, Emsley CL, Ma F, Wu Y, Ying P, Zhang Y, Gao S, Zhang W, Katz BP, Niu S, Cao S, Johnston CC (2001) Effect of long-term exposure to fluoride in drinking water on risks of bone fractures. J Bone Miner Res 16(5):932–939CrossRefPubMed
2.
go back to reference Perumal E, Paul V, Govindarajan V, Panneerselvam L (2013) A brief review on experimental fluorosis. Toxicol Lett 223(2):236–251CrossRefPubMed Perumal E, Paul V, Govindarajan V, Panneerselvam L (2013) A brief review on experimental fluorosis. Toxicol Lett 223(2):236–251CrossRefPubMed
3.
go back to reference Tucci JR, Whitford GM, McAlister WH, Novack D, Mumm S, Keaveny TM, Whyte MP (2016) Skeletal fluorosis due to inhalation abuse of a difluoroethane-containing computer cleaner. J Bone Miner Res 32(1):188–195. doi:10.1002/jbmr.2923 CrossRefPubMed Tucci JR, Whitford GM, McAlister WH, Novack D, Mumm S, Keaveny TM, Whyte MP (2016) Skeletal fluorosis due to inhalation abuse of a difluoroethane-containing computer cleaner. J Bone Miner Res 32(1):188–195. doi:10.​1002/​jbmr.​2923 CrossRefPubMed
4.
go back to reference Kurland ES, Schulman RC, Zerwekh JE, Reinus WR, Dempster DW, Whyte MP (2006) Recovery from skeletal fluorosis (an enigmatic, American case). J Bone Miner Res 22(1):163–170CrossRef Kurland ES, Schulman RC, Zerwekh JE, Reinus WR, Dempster DW, Whyte MP (2006) Recovery from skeletal fluorosis (an enigmatic, American case). J Bone Miner Res 22(1):163–170CrossRef
5.
go back to reference Whyte MP, Essmyer K, Gannon FH, Reinus WR (2005) Skeletal fluorosis and instant tea. Am J Med 118(1):78–82CrossRefPubMed Whyte MP, Essmyer K, Gannon FH, Reinus WR (2005) Skeletal fluorosis and instant tea. Am J Med 118(1):78–82CrossRefPubMed
6.
8.
go back to reference Howard MO, Bowen SE, Garland EL, Perron BE, Vaughn MG (2011) Inhalant use and inhalant use disorders in the United States. Addict Sci Clin Pract 6(1):18–31PubMedPubMedCentral Howard MO, Bowen SE, Garland EL, Perron BE, Vaughn MG (2011) Inhalant use and inhalant use disorders in the United States. Addict Sci Clin Pract 6(1):18–31PubMedPubMedCentral
9.
go back to reference Kann L, McManus T, Harris WA, Shanklin SL, Flint KH, Hawkins J, Queen B, Lowry R, Olsen EO, Chyen D, Whittle L, Thornton J, Lim C, Yamakawa Y, Brener N, Zaza S (2016) Youth risk behavior surveillance—United States, 2015. MMWR Surveill Summ 65(6):1–174. doi:10.15585/mmwr.ss6506a1 CrossRef Kann L, McManus T, Harris WA, Shanklin SL, Flint KH, Hawkins J, Queen B, Lowry R, Olsen EO, Chyen D, Whittle L, Thornton J, Lim C, Yamakawa Y, Brener N, Zaza S (2016) Youth risk behavior surveillance—United States, 2015. MMWR Surveill Summ 65(6):1–174. doi:10.​15585/​mmwr.​ss6506a1 CrossRef
10.
go back to reference MacLean S, Cameron J, Harney A, Lee NK (2012) Psychosocial therapeutic interventions for volatile substance use: a systematic review. Addiction 107(2):278–288CrossRefPubMed MacLean S, Cameron J, Harney A, Lee NK (2012) Psychosocial therapeutic interventions for volatile substance use: a systematic review. Addiction 107(2):278–288CrossRefPubMed
13.
go back to reference Teotia M, Teotia SP, Singh KP (1998) Endemic chronic fluoride toxicity and dietary calcium deficiency interaction syndromes of metabolic bone disease and deformities in India: year 2000. Indian J Pediatr 65(3):371–381CrossRefPubMed Teotia M, Teotia SP, Singh KP (1998) Endemic chronic fluoride toxicity and dietary calcium deficiency interaction syndromes of metabolic bone disease and deformities in India: year 2000. Indian J Pediatr 65(3):371–381CrossRefPubMed
Metadata
Title
Skeletal Fluorosis Due to Fluorocarbon Inhalation from an Air Dust Cleaner
Authors
Katherine Peicher
Naim M. Maalouf
Publication date
01-11-2017
Publisher
Springer US
Published in
Calcified Tissue International / Issue 5/2017
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-017-0305-0

Other articles of this Issue 5/2017

Calcified Tissue International 5/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.